CAM Use in Midlife Women in Five Ethnic Groups

说明（由申请人提供）：妇女是一般医疗保健的主要消费者，特别是补充和替代医学的主要消费者。1999年，美国妇女花费了6亿多美元用于CAM治疗更年期。关于绝经期间CAM使用的流行率、选择CAM与传统疗法治疗绝经的中年妇女的特征、不同种族/民族的CAM使用类型和流行率的差异以及绝经状态的变化，我们知之甚少。在过去的10年中，CAM用于更年期管理的营销和使用急剧增加，但很少有人知道女性对CAM的选择如何影响更年期期间传统医疗保健的使用。到2025年，美国绝经后妇女的人数将是20世纪90年代中期的两倍。妇女在选择传统激素治疗和/或CAM使用的绝经过渡期的变化和这些选择的结果是自WHI宣布以来越来越重要的主题。因此，妇女可能会求助于辅助和非辅助医疗，但对这些治疗方法的研究较少，而且不一定没有不良影响。 本申请建议对通过2006年年度随访在3300名中年妇女的多种族队列中收集的基线数据进行分析，该队列包括在全国妇女健康纵向研究（SWAN）和2002年全国健康访谈调查（NHIS）的CAM补充中。本申请的具体目的是：1）纵向检查影响CAM使用的开始和持续的人口统计学、生活方式和医学因素的种族/民族差异; 2）确定妇女在中年使用特定类型CAM的问题类型，以及这些问题是否因种族/民族而不同，并随绝经状态的变化而纵向变化;比较SWAN队列中年妇女中CAM使用的类型和原因，以及2002年NHIS补充CAM问卷中年龄和种族/民族相似的妇女中CAM使用的类型和原因。 这些目标将通过对SWAN队列从基线到第六次年度随访访视收集的现有数据进行二级数据分析，并将SWAN数据与2002年NHIS CAM使用数据进行比较以实现第三个目标。我们的假设源于对SWAN中年妇女队列中CAM使用的早期数据的初步检查。本分析的结果将做出有价值的贡献，不仅了解中年妇女使用CAM的患病率，而且还了解影响使用的因素和该年龄组使用CAM的原因，以及这些原因和决定因素以及CAM使用的类型如何因种族/民族和绝经过渡而变化。

DESCRIPTION (provided by applicant): Women are the primary consumers of health care in general and of complementary and alternative medicine (CAM) in particular. In 1999, women in the United States spent more than $600 million for CAM therapies for menopause. Little is known about the prevalence of CAM use during menopause, characteristics of midlife women who choose CAM versus conventional therapies for menopause, and differences in types and prevalence of CAM use by racial/ethnic groups and with changes in menopausal status. Marketing and use of CAM for menopause management has increased dramatically in the past 10 years, yet very little is known about how women's choices about CAM may affect use of conventional health care during menopause. By the year 2025, the number of postmenopausal women in the United States will double that of the mid-1990s Changes in women's choices in selecting conventional hormone therapy and/or CAM use across the menopausal transition and the outcomes of these choices are topics that have taken on increased importance since the WHI announcements over the past year. Women may turn to CAM as a result, but these remedies are less well-studied and not necessarily free of adverse effects. The present application proposes to undertake analyses of data collected baseline through the annual 06 follow-up visit in the multi-ethnic cohort of 3300 midlife women included in the longitudinal Study of Women's Health Across the Nation (SWAN) and the CAM Supplement to the 2002 National Health Interview Survey (NHIS). The specific aims of the present application are: 1) To examine longitudinally racial/ethnic differences in and the demographic, lifestyle and medical factors that affect initiation and continuation of CAM use; 2) To determine the types of problems for which women use specific types of CAM in midlife and whether these differ by race/ethnicity and change longitudinally with changes in menopausal status; and 3) To compare the types of and reasons for CAM use in the SWAN cohort of midlife women, to those in women of similar age and racial/ethnic groups who were administered the 2002 NHIS supplemental CAM questionnaire. These aims will be achieved through secondary data analyses of existing data collected in the SWAN cohort from baseline through the sixth annual follow-up visit and comparison of the SWAN data to the 2002 NHIS CAM use data for the third aim. Our hypotheses emanate from preliminary examination of early data on CAM use in the cohort of midlife women in SWAN. The results of the present analyses will make a valuable contribution, not only to understanding the prevalence of CAM use in midlife women, but also the factors that affect use and the reasons for CAM use in this age group and how these reasons and determinants and types of CAM use vary by race/ethnicity and over the menopausal transition.